Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference Read more about Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read more about Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics Second Quarter 2024 Earnings Results Read more about Travere Therapeutics Second Quarter 2024 Earnings Results
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read more about Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress Read more about Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
Travere Therapeutics to Present at Upcoming Investor Conferences Read more about Travere Therapeutics to Present at Upcoming Investor Conferences
Travere Therapeutics Reports First Quarter 2024 Financial Results Read more about Travere Therapeutics Reports First Quarter 2024 Financial Results
Travere Therapeutics to Report First Quarter 2024 Financial Results Read more about Travere Therapeutics to Report First Quarter 2024 Financial Results